SME Times is powered by   
Search News
Just in:   • E-commerce, social media firms must erase inactive user data after 3 years: DPDP Act  • Trump administration sues California over voter-approved Prop 50  • Adani to invest Rs 63,000 crore for two energy projects in Assam, generate thousands of jobs  • India and Russia to deepen trade ties, unlock market access  • Bihar results: EC trends show NDA’s decisive lead over grand alliance, JD(U) soars to top spot 
Last updated: 23 Sep, 2022  

who.thumb.jpg WHO warns against Covid complacency, urges for life-saving action

who.jpg
   Top Stories
» E-commerce, social media firms must erase inactive user data after 3 years: DPDP Act
» Adani to invest Rs 63,000 crore for two energy projects in Assam, generate thousands of jobs
» Latest Cabinet decisions to ensure global competitiveness, boost self-reliance: PM Modi
» Sensex, Nifty open in green over US-India trade talks, Bihar exit polls
» India, Chile agree to bolster trade, health and defence ties
IANS | 23 Sep, 2022
The World Health Organization (WHO) has warned again against complacency in fighting Covid-19, urging for coordinated action and political commitments to save lives and prevent economic and health damage from the ongoing pandemic.

"(Covid-19) pandemic is not over, but the end is in sight ... Being able to see the end does not mean we are at the end," WHO Director-General Tedros Adhanom Ghebreyesus reiterated at a press briefing on Thursday.

He cited as reasons that the pandemic is still inflicting a death toll of 10,000 per week, most of which could be prevented, while large vaccination gaps exist especially in low- and middle-income countries, Xinhua news agency reported.

"That means everyone needs to use, when needed, the simple tools that are available to stay safe: distancing, masks and ventilation. And it means everyone needs access to the medical tools to stay safe: vaccines, tests and treatments," he added.

The WHO chief's remarks came as a working group of ACT-Accelerator Facilitation Council released on Thursday its latest report, warning that the global pandemic is not over and that it's no time for Covid-19 complacency.

Co-founded by WHO and partners, the ACT-Accelerator is a global collaboration to accelerate the development, production, and equitable access to Covid-19 tests, treatments, and vaccines.

The report concludes that many countries are far from meeting global targets on vaccination coverage, testing rates, and access to treatments and PPE. And while progress is being made, the global threat of Covid-19 is far from over, particularly for high-risk groups in lower-income countries.

According to the report, Covid-19 vaccination rates in low-income countries stand only at 19 per cent, compared to almost 75 per cent in high-income countries; and the roll-out of new lifesaving Covid-19 treatments including oral antivirals in low and lower-middle income countries remain limited or non-existent.

The working group recommends that equitable access to Covid-19 countermeasures and preparation for the delivery is critical for countries to integrate the management of the virus into their primary health systems, as part of a longer-term strategy.

It highlights the decline in testing rates and the lack of equitable access to new antiviral treatments for Covid-19, emphasising that diagnostics and therapeutics, as well as associated test-to-treat strategies, are fundamental components of pandemic response, both for Covid-19 and future health threats.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter